ArticleCureus2026
Reversible Severe Left Ventricular Dysfunction in an Adolescent With Vitamin D Deficiency-Associated Hypocalcemia and Secondary Hyperparathyroidism: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypocalcemia is an uncommon but clinically important and potentially reversible metabolic contributor associated with left ventricular (LV) systolic dysfunction and heart failure. Vitamin D deficiency can precipitate hypocalcemia with secondary hyperparathyroidism, and delayed recognition may lead to severe decompensation. We report the case of a 13-year-old female patient with decompensated heart failure and dilated cardiomyopathy with severe LV dysfunction and severe functional mitral and tricuspid regurgitation. Evaluation revealed profound hypocalcemia with low ionized calcium, persistent hypomagnesemia, low 25-hydroxyvitamin D, and markedly elevated parathyroid hormone (PTH), consistent with a multifactorial metabolic derangement including vitamin D deficiency-associated secondary hyperparathyroidism. She was treated with decongestive therapy and guideline-directed heart failure pharmacotherapy alongside targeted correction of calcium, magnesium, and vitamin D deficiency. Serial echocardiography documented progressive recovery of LV systolic function (ejection fraction (EF) 35% at baseline, improving to 40% at one month and 55% at three months), and echocardiography at the one-year follow-up confirmed normal biventricular function (EF 65%) with resolution of valvular regurgitation. This case highlights that systematic screening for calcium, ionized calcium, magnesium, PTH, and vitamin D should be incorporated early in young patients with severe or disproportionate LV dysfunction because identifying metabolic contributors can alter management and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.